Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
10.69
-1.15 (-9.71%)
At close: Mar 6, 2026, 4:00 PM EST
11.10
+0.41 (3.84%)
After-hours: Mar 6, 2026, 7:58 PM EST
Tenax Therapeutics Employees
As of December 31, 2024, Tenax Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$7,221,000
Market Cap
433.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 202 |
| Century Therapeutics | 150 |
| Kyverna Therapeutics | 129 |
| Invivyd | 100 |
| CorMedix | 65 |
| Lexeo Therapeutics | 61 |
TENX News
- 4 days ago - Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 - GlobeNewsWire
- 2 months ago - Tenax Therapeutics: A Speculative Buy - Seeking Alpha
- 2 months ago - Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
- 2 months ago - Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - GlobeNewsWire
- 3 months ago - Tenax Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript - Seeking Alpha
- 4 months ago - Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire